Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
Gibson CM. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk. J Interv Cardiol. 2008 Dec; 21 Suppl 1:S3-9.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Angina, Unstable
Drug Administration Schedule
Drug Dosage Calculations
Drug Therapy, Combination
Fibrinolytic Agents
Hemorrhage
Humans
Ischemia
Myocardial Infarction
Platelet Aggregation Inhibitors
Randomized Controlled Trials as Topic
Risk Factors
Severity of Illness Index
Treatment Outcome
authors with profiles
C. Michael Gibson, M.D.